Warfarin Increases Stroke Risk in Atrial Fibrillation Patients

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
A study published in the European Heart Journal finds that atrial fibrillation patients were more likely to suffer a stroke within the first month of initiating treatment with warfarin when compared with those not using any antithrombotic therapy. Data on stroke incidence in patients newly diagnosed with atrial fibrillation was analyzed and each case of stroke was randomly matched with 10 controls. Stroke risk was significantly higher among patients who had begun taking warfarin within 30 days when compared with patients who had not used any antithrombotic therapy for at least 1 year. Patients taking warfarin had a lower risk for stroke when they had been taking the drug longer than 1 month.

To read the full article on HCPLive.com, click here.
Related Articles
Lundbeck will cease further development of its experimental desmoteplase compound for ischemic stroke.
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses what areas pharmacists should focus on during acute stroke codes.
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses a pharmacist's door-to-door discharge role when managing an ischemic stroke patient.
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses how pharmacists can enhance stroke care.
Latest Issues
$auto_registration$